US Stock MarketDetailed Quotes
WINT Windtree Therapeutics
- 1.1100
- +0.0100+0.91%
Close Oct 4 16:00 ET
- 1.1197
- +0.0097+0.87%
Post 20:02 ET
1.79MMarket Cap-58P/E (TTM)
1.2600High1.0700Low1.24MVolume1.0900Open1.1000Pre Close1.42MTurnover79.74%Turnover RatioLossP/E (Static)1.61MShares27.000052wk High0.51P/B1.72MFloat Cap1.042552wk Low--Dividend TTM1.55MShs Float3341518.3292Historical High--Div YieldTTM17.27%Amplitude1.0420Historical Low1.1440Avg Price1Lot Size
About Windtree Therapeutics Company
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
Company Profile
SymbolWINT
Company NameWindtree Therapeutics
Listing DateAug 8, 1995
Issue Price3.50
Founded1992
CEOMr. Craig E. Fraser
MarketNASDAQ
Employees15
Fiscal Year Ends12-31
Address2600 Kelly Road,Suite 100
CityWarrington
ProvincePennsylvania
CountryUnited States of America
Zip Code18976-3622
Phone1-215-488-9300
Websitehttp://www.windtreetx.com
Company Executives
- Name
- Position
- Salary
- Craig E. Fraser
- Chairman of the Board, President and Chief Executive Officer
- 693.63K
- Jamie McAndrew
- Senior Vice President, Principal Accounting Officer and Chief Financial Officer
- --
- Eric Curtis
- Senior Vice President and Chief Operating Officer
- 451.73K
- Dr. Steven G. Simonson, M.D.
- Senior Vice President and Chief Medical Officer
- 491.73K
- Saundra Pelletier
- Independent Director
- --
- Jed A. Latkin
- Independent Director
- --
- Dr. Mark Strobeck, PhD
- Lead Independent Director
- 32.34K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data